Diferencia entre revisiones de «CMV neurologic disease»

(Text replacement - "==Clinical Presentation==" to "==Clinical Features==")
(Text replacement - "==Diagnosis==" to "==Evaluation==")
Línea 5: Línea 5:
==Differential Diagnosis==
==Differential Diagnosis==


==Diagnosis==
==Evaluation==


==Management==
==Management==

Revisión del 20:48 22 jul 2016

Background

Clinical Features

Differential Diagnosis

Evaluation

Management

Antivirals

  • Ganciclovir 5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs +
    • Foscarnet 90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs

Disposition

See Also

External Links

References